Literature DB >> 16105845

Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome.

Sami Viskin1, Raphael Rosso, Ori Rogowski, Bernard Belhassen, Aviva Levitas, Abraham Wagshal, Amos Katz, Dana Fourey, David Zeltser, Antonio Oliva, Guido D Pollevick, Charles Antzelevitch, Uri Rozovski.   

Abstract

AIMS: As arrhythmias in the long QT syndrome (LQTS) are triggered by heart rate deceleration or acceleration, we speculated that the sudden bradycardia and subsequent tachycardia that follow adenosine injection would unravel QT changes of diagnostic value in patients with LQTS. METHODS AND
RESULTS: Patients (18 LQTS and 20 controls) received intravenous adenosine during sinus rhythm. Adenosine was injected at incremental doses until atrioventricular block or sinus pauses lasting 3 s occurred. The QT duration and morphology were studied at baseline and at the time of maximal bradycardia and subsequent tachycardia. Despite similar degree of adenosine-induced bradycardia (longest R-R 1.7+/-0.7 vs. 2.2+/-1.3 s for LQTS and controls, P=NS), the QT interval of LQT patients increased by 15.8+/-13.1%, whereas the QT of controls increased by only 1.5+/-6.7% (P<0.001). Similarly, despite similar reflex tachycardia (shortest R-R 0.58+/-0.07 vs. 0.55+/-0.07 s for LQT patients and controls, P=NS), LQTS patients developed greater QT prolongation (QTc=569+/-53 vs. 458+/-58 ms for LQT patients and controls, P<0.001). The best discriminator was the QTc during maximal bradycardia. Notched T-waves were observed in 72% of LQT patients but in only 5% of controls during adenosine-induced bradycardia (P<0.001).
CONCLUSION: By provoking transient bradycardia followed by sinus tachycardia, this adenosine challenge test triggers QT changes that appear to be useful in distinguishing patients with LQTS from healthy controls.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105845      PMCID: PMC1474076          DOI: 10.1093/eurheartj/ehi460

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  31 in total

1.  Is exercise testing useful in identifying congenital long QT syndrome?

Authors:  Rejane F Dillenburg; Robert M Hamilton
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

Review 2.  Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.

Authors:  G M Vincent
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

3.  Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.

Authors:  Michael J Ackerman; Anant Khositseth; David J Tester; Joseph B Hejlik; Win-Kuang Shen; Co-burn J Porter
Journal:  Mayo Clin Proc       Date:  2002-05       Impact factor: 7.616

4.  Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population.

Authors:  W C Allan; K Timothy; G M Vincent; G E Palomaki; L M Neveux; J E Haddow
Journal:  J Med Screen       Date:  2001       Impact factor: 2.136

5.  The adenosine triphosphate test: a bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations.

Authors:  S Viskin; R Fish; A Glick; M Glikson; M Eldar; B Belhassen
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

Review 6.  Long QT syndromes and torsade de pointes.

Authors:  S Viskin
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

7.  Electrical behavior of T-wave polarity alternans in patients with congenital long QT syndrome.

Authors:  F E Cruz Filho; I G Maia; M L Fagundes; R C Barbosa; P A Alves; R M Sá; S H Boghossian; J C Ribeiro
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

Review 8.  Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?

Authors:  S Viskin; R Fish; D Zeltser; B Belhassen; K Heller; D Brosh; S Laniado; H V Barron
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

9.  Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome.

Authors:  Wataru Shimizu; Takashi Noda; Hiroshi Takaki; Takashi Kurita; Noritoshi Nagaya; Kazuhiro Satomi; Kazuhiro Suyama; Naohiko Aihara; Shiro Kamakura; Kenji Sunagawa; Shigeyuki Echigo; Kazufumi Nakamura; Tohru Ohe; Jeffrey A Towbin; Carlo Napolitano; Silvia G Priori
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

10.  Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome.

Authors:  Kotoe Takenaka; Tomohiko Ai; Wataru Shimizu; Atsushi Kobori; Tomonori Ninomiya; Hideo Otani; Tomoyuki Kubota; Hiroshi Takaki; Shiro Kamakura; Minoru Horie
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

View more
  11 in total

1.  Effects of head-up tilt-table test on the QT interval.

Authors:  Michael Findler; Amir Birger; Shmuel Diamant; Sami Viskin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

2.  The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome.

Authors:  Arnon Adler; Christian van der Werf; Pieter G Postema; Raphael Rosso; Zahir A Bhuiyan; Jonathan M Kalman; Jitendra K Vohra; Milton E Guevara-Valdivia; Manlio F Marquez; Amir Halkin; Jesaia Benhorin; Charles Antzelevitch; Arthur A M Wilde; Sami Viskin
Journal:  Heart Rhythm       Date:  2012-01-31       Impact factor: 6.343

3.  Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes.

Authors:  Sandro L Yong; Ying Ni; Teng Zhang; David J Tester; Michael J Ackerman; Qing K Wang
Journal:  Biochem Biophys Res Commun       Date:  2006-11-14       Impact factor: 3.575

4.  Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.

Authors:  Dan Hu; Sami Viskin; Antonio Oliva; Tabitha Carrier; Jonathan M Cordeiro; Hector Barajas-Martinez; Yuesheng Wu; Elena Burashnikov; Serge Sicouri; Ramon Brugada; Rafael Rosso; Alejandra Guerchicoff; Guido D Pollevick; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-04-10       Impact factor: 6.343

Review 5.  Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology.

Authors:  S Jamal Mustafa; R Ray Morrison; Bunyen Teng; Amir Pelleg
Journal:  Handb Exp Pharmacol       Date:  2009

6.  ATPace™: injectable adenosine 5'-triphosphate : Diagnostic and therapeutic indications.

Authors:  Amir Pelleg; Steven P Kutalek; Daniel Flammang; David Benditt
Journal:  Purinergic Signal       Date:  2011-11-06       Impact factor: 3.765

7.  LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current.

Authors:  Eyal Nof; Hector Barajas-Martinez; Michael Eldar; Janire Urrutia; Gabriel Caceres; Gail Rosenfeld; David Bar-Lev; Micha Feinberg; Elena Burashnikov; Oscar Casis; Dan Hu; Michael Glikson; Charles Antzelevitch
Journal:  Europace       Date:  2011-06-28       Impact factor: 5.214

8.  Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.

Authors:  Eyal Nof; Bernard Belhassen; Michael Arad; Zahurul A Bhuiyan; Charles Antzelevitch; Raphael Rosso; Rami Fogelman; David Luria; Dalia El-Ani; Marcel M A M Mannens; Sami Viskin; Michael Eldar; Arthur A M Wilde; Michael Glikson
Journal:  Heart Rhythm       Date:  2011-05-26       Impact factor: 6.343

9.  Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias.

Authors:  Dan Hu; Sami Viskin; Antonio Oliva; Jonathan M Cordeiro; Alejandra Guerchicoff; Guido D Pollevick; Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

10.  Mouse Models of SCN5A-Related Cardiac Arrhythmias.

Authors:  Mickael Derangeon; Jérôme Montnach; Isabelle Baró; Flavien Charpentier
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.